Perrier, F.
Viallon, V.
Ambatipudi, S.
Ghantous, A.
Cuenin, C.
Hernandez-Vargas, H.
Chajès, V.
Baglietto, L.
Matejcic, M.
Moreno-Macias, H.
Kühn, T.
Boeing, H.
Karakatsani, A.
Kotanidou, A.
Trichopoulou, A.
Sieri, S.
Panico, S.
Fasanelli, F.
Dolle, M.
Onland-Moret, C.
Sluijs, I.
Weiderpass, E.
Quirós, J. R.
Agudo, A.
Huerta, J. M.
Ardanaz, E.
Dorronsoro, M.
Tong, T. Y. N.
Tsilidis, K.
Riboli, E.
Gunter, M. J.
Herceg, Z.
Ferrari, P.
Romieu, I.
Funding for this research was provided by:
Fondation de France (2015 00060737)
Institut National du Cancer (2012-070, 2012-070)
Seventh Framework Programme (260791)
Fondation Association pour la Recherche contre le Cancer
FP7 People: Marie-Curie Actions
Ligue Nationale Contre le Cancer
Medical Research Council and the University of Bristol (MC_UU_00011/1, MC_UU_00011/4 and MC_UU_00011/5)
Article History
Received: 12 November 2018
Accepted: 20 February 2019
First Online: 2 April 2019
Ethics approval and consent to participate
: The study was approved by the Ethical Review Board of the International Agency for Research on Cancer, and by the local Ethics Committees in the participating centres. This study was also conducted in accordance with the IARC Ethic Committee (Project No 10-22).
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.